Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

Also called NCT01689142

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 240 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01689142
Other papers using this trial's data
  • New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2) Diabetes, obesity & metabolism, 2016-04 DOI, PubMed 26662838, PMC5066636 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01689142. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
Acronym
EDITION JP II
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Insulin glargine new formulation (HOE901)
Intervention (Drug)
Insulin glargine (HOE901)
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01689142
Content hash
b827f29b2b4973ee29dc8aee59958de80895010d06805b13621d3134b6a509c2